Pure Red Cell Aplasia Associated with Imatinib-Treated FIP1L1-PDGFRA Positive Chronic Eosinophilic Leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pure Red Cell Aplasia Associated with Imatinib-Treated FIP1L1-PDGFRA Positive Chronic Eosinophilic Leukemia

Published:2010 Issue:12 Volume:49 Page:1195-1200
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Tanaka Hideo¹²,Iwato Koji³,Asou Hiroya⁴,Kimura Akiro²

Affiliation:

1. Department of Hematology, Hiroshima City Asa Hospital

2. Department of Hematology & Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University

3. Department of Blood Transfusion, Hiroshima Red Cross and Atomic Bomb Survivors Hospital

4. Department of Molecular Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

http://www.jstage.jst.go.jp/article/internalmedicine/49/12/49_12_1195/_pdf

Reference24 articles.

1. THE HYPEREOSINOPHILIC SYNDROME

2. Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate

3. Treatment of hypereosinophilic syndrome with imatinib mesilate

4. A Tyrosine Kinase Created by Fusion of thePDGFRAandFIP1L1Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imatinib-induced severe hematological toxicity: Prolonged myelosuppression resulting from extraordinary sensitivity in an old age;European Journal of Inflammation;2023-02-15

2. Chronic Myeloid Leukaemias;Leukaemia Diagnosis;2017-03-25

3. TKI-induced pure red cell aplasia: first case report of pure red cell aplasia with both imatinib and nilotinib;ESMO Open;2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3